Re: Zenith Epigenetics is proud to announce the appointment Dr. Brad Thompson, PhD to our Board of Directors!
posted on
Sep 01, 2023 04:32AM
Zenith's BET Inhibitor ZEN-3694 is Currently Being Evaluated in Multiple Oncology Clinical Trials
I believe that the information you share, will bring a lot of value to the readers and I hope that they will absorb the good and useful things. The Password Game